Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma
Pinato DJ., Brown MW., Trousil S., Aboagye EO., Beaumont J., Zhang H., Coley HM., Mauri FA., Sharma R.